Compounds > modafinil

modafinil and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

modafinil has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agnati, LF; Altamimi, U; Andbjer, B; Finnman, UB; Fuxe, K; Goldstein, M; Janson, AM; Rosén, L; Ueki, A1
Aguirre, JA; Antonelli, T; Cintra, A; Ferraro, L; Fuxe, K; Hillion, J; Jansson, A; Narváez, JA; Rambert, FA1
Chancharme, L; Jenner, P; Moachon, G; Pearce, RK; Smith, LA; Tel, B; Zeng, BY1
Jongsma, MJ; Olivier, B; Philippens, IH; van der Gugten, J; van Vliet, SA; Vanwersch, RA1
Blezer, EL; Jongsma, MJ; Olivier, B; Philippens, IH; van Vliet, SA; van Vlieta, SA; Vanwersch, RA1

Other Studies

5 other study(ies) available for modafinil and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Experimental brain research, 1993, Volume: 93, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Arousal; Benzhydryl Compounds; Biogenic Monoamines; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Male; Modafinil; Nerve Degeneration; Neural Pathways; Neurons; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase

1993
A stereological study on the neuroprotective actions of acute modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse.
    Neuroscience letters, 1999, Nov-19, Volume: 275, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzhydryl Compounds; Dopamine; Male; Mice; Mice, Inbred C57BL; Modafinil; MPTP Poisoning; Neurons; Neuroprotective Agents; Substantia Nigra; Tyrosine 3-Monooxygenase

1999
Modafinil prevents the MPTP-induced increase in GABAA receptor binding in the internal globus pallidus of MPTP-treated common marmosets.
    Neuroscience letters, 2004, Jan-02, Volume: 354, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzhydryl Compounds; Callithrix; Dopamine Agents; Female; Flunitrazepam; GABA Modulators; Globus Pallidus; Male; Modafinil; MPTP Poisoning; Neuroprotective Agents; Receptors, GABA-A; Tritium

2004
Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects.
    Behavioural pharmacology, 2006, Volume: 17, Issue:5-6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Arousal; Benzhydryl Compounds; Callithrix; Corpus Striatum; Dopamine; Humans; Male; Modafinil; Motor Activity; Motor Skills; Neuroprotective Agents; Parkinsonian Disorders; Psychomotor Performance; Reflex, Startle

2006
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    Brain research, 2008, Jan-16, Volume: 1189

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Benzhydryl Compounds; Biomarkers; Brain; Callithrix; Disease Models, Animal; Dopamine; Drug Administration Schedule; Immunohistochemistry; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Modafinil; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Phosphocreatine; Predictive Value of Tests; Reproducibility of Results; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase

2008